Abstract
Introduction

Carbamazepine (CBZ) is widely used for the treatment of seizure disorders, trigeminal neuralgia, and affective disorders. Like tricyclic antidepressants, CBZ has quinidine-like effects on cardiac conduction. Bradyarrhythmias or atrioventricular conduction delays have rarely been reported, predominantly in elderly women, during the course of routine treatment with either therapeutic or modestly elevated serum concentrations of the drug (1).
Case Report
. The serum concentrations of the drug reported in two patients were within the therapeutic range (8, 9) . However, Labrecque et al described a 63-year-old woman who presented with exertional dyspnea long (3 years) after the initiation of CBZ therapy (10) 
